EuBiologics Co., Ltd. (KOSDAQ: 206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,360
+390 (3.91%)
Sep 11, 2024, 11:08 AM KST

EuBiologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
383,610418,137324,3591,271,414655,399
Market Cap Growth
28.91%28.91%-74.49%93.99%-
Enterprise Value
380,342418,132320,5501,239,111-
Last Close Price
10500.0011470.008900.0035050.0021300.00
PE Ratio
--30.10-294.83-45.05-9.92
PS Ratio
5.526.035.8532.2823.00
PB Ratio
3.443.992.7210.846.77
P/FCF Ratio
19.6621.43-123.50-89.56-102.88
P/OCF Ratio
15.8115.8150.37-167.25395.02
EV/Sales Ratio
5.486.035.7831.46-
EV/EBITDA Ratio
23.2624.7977.93-1861.89-
EV/EBIT Ratio
52.9254.31-85.06-171.40-
EV/FCF Ratio
19.4921.43-122.05-87.28-
Debt / Equity Ratio
0.140.140.130.130.23
Debt / EBITDA Ratio
0.880.883.81--
Debt / FCF Ratio
0.760.76-5.96-1.09-3.54
Asset Turnover
0.440.440.350.26-
Inventory Turnover
2.262.261.952.01-
Quick Ratio
0.770.770.591.991.65
Current Ratio
1.631.631.673.112.03
Return on Equity (ROE)
-13.70%-13.70%-2.90%-26.17%-
Return on Assets (ROA)
3.07%3.07%-1.51%-2.95%-
Return on Capital (ROIC)
3.78%3.78%-1.76%-3.58%-
Earnings Yield
-3.63%-3.32%-0.34%-2.17%-9.18%
FCF Yield
5.09%4.67%-0.81%-1.12%-0.97%
Buyback Yield / Dilution
-0.13%-0.13%-2.68%-26.53%-
Total Shareholder Return
-0.13%-0.13%-2.68%-26.53%-
Source: S&P Capital IQ. Standard template. Financial Sources.